In terms of treatment trajectories (Figure), patient 1 was a 75-year-old female ex-smoker with clinical stage IIIa (cT4N0M0; T4 due to tumor size) EGFR-mutated invasive acinar-predominant lung adenocarcinoma. This evidence concerns the gene EGFR and lung adenocarcinoma.